Refika Hande Karakahya1, Tuba Şaziye Özcan2. 1. Department of Ophthalmology, Ordu University School of Medicine, Ordu, Turkey. handekarakahya@gmail.com. 2. Department of Neurology, Ordu University School of Medicine, Ordu, Turkey.
Abstract
PURPOSE: The evaluation of the short-term effect of topically applied coenzyme Q10 (CoQ10) on retina and choroid in Alzheimer's disease (AD) was aimed in this study. METHODS: Randomized controlled study included a total of 93 patients, 62 of whom with AD. Thirty (32.3%) AD patients received treatment (Group 1), 32 (34.4%) AD patients observed without treatment (Group 2), and Group 3 included 31 (33.3%) healthy controls (HC). Neurological and ophthalmological examinations including optical coherence tomography (OCT) were executed. RESULTS:Retinal nerve fiber layer (RNFL) thickness in all quadrants increased following CoQ10 treatment in Group 1; however significant rise yielded in average and temporal quadrant RNFL thickness. Average and superonasal sector ganglion cell-inner plexiform layer (GCIPL) thickness increased significantly following CoQ10 treatment. The correlation analysis between difference in pre- and posttreatment OCT values in Group 1 revealed that rise in average RNFL thickness was inversely correlated with duration of the disease and rise in average GCIPL thickness and superonasal sector thickness was inversely correlated with severity of the disease. CONCLUSION: Short-term topical CoQ10 resulted in improvement in AD related retinal ganglion cell (RGC) loss which may reflect the salvage of some RGCs in the reversible transitional phase. More bioavailability through intravitreal route of administration and longer duration of effect with sustained release forms may possibly help enhalting the RGC loss, especially incipience of neurodegenerative diseases.
RCT Entities:
PURPOSE: The evaluation of the short-term effect of topically applied coenzyme Q10 (CoQ10) on retina and choroid in Alzheimer's disease (AD) was aimed in this study. METHODS: Randomized controlled study included a total of 93 patients, 62 of whom with AD. Thirty (32.3%) ADpatients received treatment (Group 1), 32 (34.4%) ADpatients observed without treatment (Group 2), and Group 3 included 31 (33.3%) healthy controls (HC). Neurological and ophthalmological examinations including optical coherence tomography (OCT) were executed. RESULTS:Retinal nerve fiber layer (RNFL) thickness in all quadrants increased following CoQ10 treatment in Group 1; however significant rise yielded in average and temporal quadrant RNFL thickness. Average and superonasal sector ganglion cell-inner plexiform layer (GCIPL) thickness increased significantly following CoQ10 treatment. The correlation analysis between difference in pre- and posttreatment OCT values in Group 1 revealed that rise in average RNFL thickness was inversely correlated with duration of the disease and rise in average GCIPL thickness and superonasal sector thickness was inversely correlated with severity of the disease. CONCLUSION: Short-term topical CoQ10 resulted in improvement in AD related retinal ganglion cell (RGC) loss which may reflect the salvage of some RGCs in the reversible transitional phase. More bioavailability through intravitreal route of administration and longer duration of effect with sustained release forms may possibly help enhalting the RGC loss, especially incipience of neurodegenerative diseases.
Authors: Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: Tauheed Ishrat; M Badruzzaman Khan; Md Nasrul Hoda; Seema Yousuf; Muzamil Ahmad; Mubeen A Ansari; Abdullah S Ahmad; Fakhrul Islam Journal: Behav Brain Res Date: 2006-04-18 Impact factor: 3.332
Authors: Michael R Banitt; Lori M Ventura; William J Feuer; Eleonore Savatovsky; Gabriel Luna; Olga Shif; Brandon Bosse; Vittorio Porciatti Journal: Invest Ophthalmol Vis Sci Date: 2013-03-28 Impact factor: 4.799
Authors: Fatmire Berisha; Gilbert T Feke; Clement L Trempe; J Wallace McMeel; Charles L Schepens Journal: Invest Ophthalmol Vis Sci Date: 2007-05 Impact factor: 4.799
Authors: Mario Durán-Prado; Javier Frontiñán; Raquel Santiago-Mora; Juan Ramón Peinado; Cristina Parrado-Fernández; María Victoria Gómez-Almagro; María Moreno; José Alberto López-Domínguez; José Manuel Villalba; Francisco J Alcaín Journal: PLoS One Date: 2014-10-01 Impact factor: 3.240